Kojima, S., Masuda, H., Suyama, T., Hou, K., Mikami, K., Araki, K., & Naya, Y. High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy. Wiley.
Chicago Style (17th ed.) CitationKojima, Satoko, Hiroshi Masuda, Takahito Suyama, Kyokushin Hou, Kousuke Mikami, Kazuhiro Araki, and Yukio Naya. High Serum Alkaline Phosphatase Flare After First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy. Wiley.
MLA (9th ed.) CitationKojima, Satoko, et al. High Serum Alkaline Phosphatase Flare After First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted Therapy. Wiley.